Effects of Limicol on LDL-cholesterol

Lescuyer Laboratory

Status: Completed

Conditions: Hypercholesteremia

Treatments: Dietary Supplement: Limicol; Dietary Supplement: Placebo

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT01354327

2008-A01169-46

Details and patient eligibility

About

The principal objective of this study is to investigate the effects of a novel food supplement (Limicol) on LDL-cholesterol levels in healthy subjects with moderate hypercholesterolemia.

Enrollment: 47 patients

Sex: All

Ages: 18 to 55 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• About 18 to 55 years (inclusive)
• Subject has a stable weight for at least three months before the start of the study
• Subject able and willing to comply with the protocol and agreeing to give their consent in writing
• Subject affiliated with a social security scheme
• Subject willing to be included in the national register of volunteers who lend themselves to biomedical research

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

47 participants in 2 patient groups, including a placebo group

Limicol

Experimental group

Treatment:

Dietary Supplement: Limicol

Placebo

Placebo Comparator group

Treatment:

Dietary Supplement: Placebo